New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
09:03 EDTPETM, LULU, NQ, APP, PCAR, ISCA, BIND, AMGN, RGDOOn The Fly: Pre-market Movers
HIGHER: PetSmart (PETM), up 16% after activist investor Jana Partners disclosed that it has acquired a 9.9% stake and intends to have talks with PetSmartís board of directors and management regarding a review of strategic alternatives including exploring a sale... American Apparel (APP), up 9.6% after deposed CEO Dov Charney reportedly surrendered his entire stake and voting rights in the retailer to hedge fund Standard General, according to Reuters... International Speedway (ISCA), up 4% after reporting Q2 adjusted EPS and revenue that beat expectations... PACCAR (PCAR), up 4% after research reports said Daimler's (DDAIY) truck chief claimed to have been told that Volkswagen (VLKAY) wants to take over the truck maker, though a spokesman for Volkswagen told Dow Jones that there is "no truth" to the reports that it is planning an acquisition bid... lululemon (LULU), up 3.7% after The Wall Street Journal reported last night, citing people familiar with the situation, that the company's founder has been talking to private equity firms through advisers about taking the company private. LOWER: Regado Biosciences (RGDO), down 54% after announcing that the Data Safety Monitoring Board has initiated an unplanned review of data from the REGULATE-PCI trial and the stock was downgraded to Underperform from Outperform at Wedbush... NQ Mobile (NQ), down 21.5% after reporting that its auditor, PwC, has requested to expand the scope of its 2013 audit work and that the audit committee chair is stepping down from the board... BIND Therapeutics (BIND), down 13% after announcing Amgen (AMGN) will not be exercising its development option under the companies' collaborative research program.
News For PETM;LULU;NQ;APP;PCAR;ISCA;BIND;AMGN;RGDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 21, 2014
07:15 EDTAMGNFDA to hold workshop on breast cancer drug development
Subscribe for More Information
06:26 EDTNQStocks with implied volatility above IV index mean; NQ CMG
Subscribe for More Information
October 20, 2014
07:19 EDTAMGNIBC Life Sciences to hold a conference
Subscribe for More Information
October 19, 2014
15:56 EDTAMGNAmgen to aid in production method for Ebola drug ZMapp, Bloomberg says
Subscribe for More Information
October 17, 2014
09:06 EDTAMGNAmgen files patent infringement lawsuit against Sanofi, Regeneron
Amgen (AMGN) announced that it filed a lawsuit in the United States District Court of Delaware against Sanofi (SNY), Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals (REGN) for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9, or PCSK9. By its complaint, Amgen seeks an injunction to prevent the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9. Sanofi and Regeneron recently announced that they have completed Phase 3 clinical trials on alirocumab and intend to pursue regulatory approval to market alirocumab in the U.S. Amgen previously announced submission of a Biologics License Application to the FDA for evolocumab, its own investigational human monoclonal antibody to PCSK9, for the treatment of high cholesterol, on Aug. 28.
October 16, 2014
11:36 EDTNQOptions with increasing implied volatility
Options with increasing implied volatility: UVXY NQ PVA SVXY VXX SUNE CIE COV ZU CODE
10:01 EDTLULUOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Akamai (AKAM) downgraded to Market Perform from Outperform at Wells Fargo... CGG SA (CGG) downgraded to Reduce from Neutral at Nomura... Central Valley Community (CVCY) downgraded to Hold from Buy at Sandler O'Neill... DSM (RDSMY) downgraded to Neutral from Buy at Nomura... Disney (DIS) downgraded at Guggenheim... Francesca's (FRAN) downgraded to Underperform from Outperform at Macquarie... Netflix (NFLX) downgraded to Fair Value from Buy at CRT Capital... Nordstrom (JWN) downgraded to Neutral from Outperform at Macquarie... Norfolk Southern (NSC) downgraded at Credit Suisse... Rio Tinto (RIO) downgraded to Market Perform at Cowen... Seadrill (SDRL) downgraded to Reduce from Neutral at Nomura... Ternium (TX) downgraded to Neutral from Overweight at JPMorgan... Urban Outfitters (URBN) downgraded to Neutral from Outperform at Macquarie... Viacom (VIAB) downgraded at BofA/Merrill... eBay (EBAY) downgraded to Underperform from Buy at CLSA... lululemon (LULU) downgraded to Underperform from Neutral at Macquarie.
05:39 EDTLULUlululemon downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded lululemon to Underperform after assuming coverage of the stock saying the company's expansion into Asia and Europe will drive a meaningful increase in spending. The firm lowered its price target for shares to $34 from $40.
October 15, 2014
17:48 EDTAPPAmerican Apparel to make interest payment on bonds, Bloomberg says
According to sources retail chain American Apparel will make an interest payment on its bonds, says Bloomberg. American Apparel will make a payment of about $13M by todayís due date, added Bloomberg. Reference Link
October 14, 2014
11:23 EDTBIND, AMGNBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 13, 2014
14:02 EDTLULUlululemon's Q3 sales tracking below consensus, says ITG Research
Subscribe for More Information
October 10, 2014
07:31 EDTRGDORegado Biosciences appoints Michael Metzger CEO
Regado Biosciences announced the appointment of Michael Metzger, President of Regado, to the additional post of CEO and as a member of the board effective immediately. Metzger previously served as president and chief operating officer of Regado. He replaces David Mazzo, who has resigned from the company.
October 9, 2014
16:11 EDTAMGNAmgen blinatumomab granted priority review by FDA
Subscribe for More Information
10:50 EDTAPPGap falls after announcing CEO Murphy will step down, weak September sales
Subscribe for More Information
06:10 EDTLULUStocks with implied volatility below IV index mean; NKE LULU
Subscribe for More Information
October 8, 2014
10:20 EDTAMGNAmgen biosimilar franchise underappreciated, says Piper Jaffray
After Amgen announced positive Phase 3 results for its biosimilar Humira in psoriasis, Piper Jaffray said it believes that Amgen's overall pipeline is underappreciated since the company's biosimilar franchise is generally not included in consensus estimates. The firm views Amgen as a top large cap picks and reiterate its Overweight rating on the stock.
09:16 EDTAMGNAmgen's ABP 501 for psoriasis shows positive Phase 3 results
Subscribe for More Information
07:19 EDTAMGNCBI to hold a conference
Subscribe for More Information
07:11 EDTAMGNEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
06:00 EDTLULUStocks with implied volatility below IV index mean; ADHD LULU
Stocks with implied volatility below IV index mean; Alcobra (ADHD) 123, lululemon (LULU) 35 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use